PRIMMUNE THERAPEUTICS
Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer immunotherapies, such as checkpoint inhibitors, to improve overall response rates and treatment durability.
PRIMMUNE THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.primmunerx.com
Total Employee:
1+
Status:
Active
Total Funding:
48.33 M USD
Similar Organizations
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
Telum Therapeutics
Telum Therapeutics is a biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bioqube Ventures
Bioqube Ventures investment in Series A - Primmune Therapeutics
BioRock Ventures
BioRock Ventures investment in Series A - Primmune Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series A - Primmune Therapeutics
Oberland Capital
Oberland Capital investment in Series A - Primmune Therapeutics
Charlie McDermott
Charlie McDermott investment in Series A - Primmune Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Primmune Therapeutics
BioBrit
BioBrit investment in Series A - Primmune Therapeutics
CAM Capital
CAM Capital investment in Series A - Primmune Therapeutics
Charlie McDermott
Charlie McDermott investment in Seed Round - Primmune Therapeutics
CAM Capital
CAM Capital investment in Seed Round - Primmune Therapeutics
Official Site Inspections
http://www.primmunerx.com
- Host name: 152.0.198.104.bc.googleusercontent.com
- IP address: 104.198.0.152
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
